The Prostate Cancer Clinical Trials Consortium (PCCTC) is a leading multi-centre research organisation dedicated to advancing prostate cancer treatment across the US. Based in New York City, its expert management team provides comprehensive Contract Research Organisation (CRO) services, combining operational excellence with scientific expertise to accelerate trial activation, patient accrual, and study completion.
The PCCTC approached The DPO Centre for support in meeting its Article 27 obligations and managing its data protection responsibilities across Europe.
To meet obligations under Article 27 of the GDPR, The Prostate Cancer Clinical Trials Consortium (PCCTC) appointed The DPO Centre to act as its EU Representative.
The designated DPO and supporting team began with a high-level review and data mapping exercise to understand how PCCTC processes personal data belonging to EEA residents. This informed the preparation of PCCTC’s Record of Processing Activities (RoPA), as required under Article 30. These records are regularly maintained and updated to ensure ongoing compliance.
As PCCTC’s EU Representative, The DPO Centre also acts as the point of contact for supervisory authorities across all EU Member States and represents the organisation in responding to Data Subject Access Requests (DSARs) and other rights-related requests, including those requiring local language support.
Drew Davies, Contracts Manager at the PCCTC, said:
‘By having The DPO Centre take responsibility for the role of GDPR Representative for the PCCTC, we are confident we are meeting the legal requirements of the GDPR. The initial data mapping and construction of our RoPA were a great help in understanding the practicalities of the legislation and what the consortium’s obligations are. The DPO Centre’s team are always on hand to answer any queries we may have and to help us respond to any Data Subject Access Requests from any trial member across the EU.’